Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
8.96
+0.18 (2.05%)
At close: Feb 21, 2025, 4:00 PM
8.76
-0.20 (-2.23%)
After-hours: Feb 21, 2025, 6:37 PM EST
Pulmonx Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Revenue | 83.79 | 68.68 | 53.66 | 48.42 | 32.73 | |
Revenue Growth (YoY) | 22.01% | 27.98% | 10.84% | 47.91% | 0.42% | |
Cost of Revenue | 21.79 | 17.92 | 13.8 | 12.79 | 11.53 | |
Gross Profit | 62 | 50.75 | 39.87 | 35.63 | 21.2 | |
Selling, General & Admin | 102.14 | 94.61 | 83.11 | 69.87 | 46.07 | |
Research & Development | 17.57 | 18.08 | 15.4 | 13.06 | 7.46 | |
Operating Expenses | 119.71 | 112.69 | 98.5 | 82.93 | 53.53 | |
Operating Income | -57.7 | -61.94 | -58.64 | -47.3 | -32.33 | |
Interest Expense | -3.51 | -3.23 | -1.07 | -0.83 | -3.18 | |
Interest & Investment Income | 5.06 | 5.57 | 1.53 | 0.4 | 0.21 | |
Currency Exchange Gain (Loss) | - | -0.8 | -0.4 | -0.59 | 0.1 | |
Other Non Operating Income (Expenses) | 0.26 | 0.13 | - | - | 3.18 | |
Pretax Income | -55.89 | -60.27 | -58.57 | -48.32 | -32.02 | |
Income Tax Expense | 0.5 | 0.57 | 0.35 | 0.34 | 0.21 | |
Net Income | -56.39 | -60.84 | -58.92 | -48.66 | -32.23 | |
Net Income to Common | -56.39 | -60.84 | -58.92 | -48.66 | -32.23 | |
Shares Outstanding (Basic) | 39 | 38 | 37 | 36 | 10 | |
Shares Outstanding (Diluted) | 39 | 38 | 37 | 36 | 10 | |
Shares Change (YoY) | 2.99% | 2.37% | 2.68% | 254.74% | 473.44% | |
EPS (Basic) | -1.44 | -1.60 | -1.59 | -1.35 | -3.16 | |
EPS (Diluted) | -1.44 | -1.60 | -1.59 | -1.35 | -3.16 | |
Free Cash Flow | - | -38.42 | -46.4 | -45.06 | -31.54 | |
Free Cash Flow Per Share | - | -1.01 | -1.25 | -1.25 | -3.10 | |
Gross Margin | 74.00% | 73.90% | 74.29% | 73.59% | 64.77% | |
Operating Margin | -68.87% | -90.19% | -109.27% | -97.70% | -98.77% | |
Profit Margin | -67.30% | -88.60% | -109.80% | -100.51% | -98.47% | |
Free Cash Flow Margin | - | -55.94% | -86.47% | -93.07% | -96.37% | |
EBITDA | -56.11 | -60.39 | -57.12 | -46.44 | -31.85 | |
EBITDA Margin | -66.96% | -87.93% | -106.45% | -95.91% | -97.30% | |
D&A For EBITDA | 1.6 | 1.55 | 1.51 | 0.87 | 0.48 | |
EBIT | -57.7 | -61.94 | -58.64 | -47.3 | -32.33 | |
EBIT Margin | -68.87% | -90.19% | -109.27% | -97.70% | -98.77% | |
Advertising Expenses | - | 4.8 | 6.1 | 5.1 | 1.5 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.